Metformin plus sorafenib highly impacts temozolomide resistant glioblastoma stem-like cells.
Aldea MD, Petrushev B, Soritau O, Tomuleasa CI, Berindan-Neagoe I, Filip AG, Chereches G, Cenariu M, Craciun L, Tatomir C, Florian IS, Crivii CB, Kacso G.
Aldea MD, et al. Among authors: florian is.
J BUON. 2014 Apr-Jun;19(2):502-11.
J BUON. 2014.
PMID: 24965413
Free article.